SAM CHUN DANG PHARM CO. LTD Q3 operating profit KRW 3.5 billion on KRW 69.2 billion revenue; net loss

What happened

Samchundang Pharm filed its quarterly report with consolidated results for the 3rd quarter.

In the company's terms

Sales for the 3 months were KRW 69.16 billion. That is 19.2% more than the same 3 months a year earlier (KRW 58.02 billion). It is 2.2% less than the previous quarter.

What changes for shareholders

Operating profit (profit from the core business) for the 3 months was KRW 3.55 billion. That is 3.4% more than a year earlier (KRW 3.43 billion) and 3.2% more than the previous quarter.

Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 1.37 billion. A year earlier it was a profit of KRW 4.46 billion. The previous quarter was a profit, so the company swung to a loss this time.

For the year to date (2026.01.01 to 2026.09.30), sales were KRW 204.77 billion. Operating profit was KRW 12.44 billion and net income was KRW 11.73 billion.